Mirae Asset Global Investments’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-25,779
| Closed | -$938K | – | 1719 |
|
|
2024
Q1 | $938K | Sell |
25,779
-479
| -2% | -$17.4K | ﹤0.01% | 1575 |
|
|
2023
Q4 | $1.04M | Buy |
26,258
+962
| +4% | +$38.2K | ﹤0.01% | 1598 |
|
|
2023
Q3 | $696K | Sell |
25,296
-1,730
| -6% | -$47.6K | ﹤0.01% | 1722 |
|
|
2023
Q2 | $922K | Buy |
27,026
+1,511
| +6% | +$51.5K | ﹤0.01% | 1617 |
|
|
2023
Q1 | $918K | Buy |
25,515
+5,986
| +31% | +$215K | ﹤0.01% | 1593 |
|
|
2022
Q4 | $870K | Hold |
19,529
| – | – | ﹤0.01% | 1572 |
|
|
2022
Q3 | $549K | Buy |
19,529
+5,780
| +42% | +$162K | ﹤0.01% | 1817 |
|
|
2022
Q2 | $371K | Buy |
+13,749
| New | +$371K | ﹤0.01% | 1888 |
|